发明授权
- 专利标题: Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides
- 专利标题(中): 缩短生产荚膜肺炎链球菌多糖的纯化方法
-
申请号: US12052525申请日: 2008-03-20
-
公开(公告)号: US08652480B2公开(公告)日: 2014-02-18
- 发明人: Yonghui Yuan , Mark Ruppen , Wei-Qiang Sun , Ling Chu , John Simpson , James Patch , Justin Keith Moran , Pamela Fink
- 申请人: Yonghui Yuan , Mark Ruppen , Wei-Qiang Sun , Ling Chu , John Simpson , James Patch , Justin Keith Moran , Pamela Fink
- 申请人地址: US NJ Madison
- 专利权人: Wyeth LLC
- 当前专利权人: Wyeth LLC
- 当前专利权人地址: US NJ Madison
- 代理商 Royal N. Ronning, Jr.
- 主分类号: A61K31/70
- IPC分类号: A61K31/70 ; A61K39/00
摘要:
A shortened process for producing a solution containing substantially purified capsular polysaccharides from a cellular Streptococcus pneumoniae lysate broth is described. Ultrafiltering and diafiltering a clarified S. pneumoniae lysate followed by pH adjustment to less than 4.5, preferably about 3.5, precipitated at least 98% of the protein in the solution without seriously affecting polysaccharide yield. Furthermore, following ultrafiltration and diafiltration and acidification to a pH of less than 4.5, filtration using activated carbon precipitated at least 90% of remaining protein without seriously affecting polysaccharide yield. Exemplary, non-limiting S. pneumoniae serotypes that can be purified using the shortened process of the invention are 1, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. In one embodiment, the Streptococcus pneumoniae cells are lysed using deoxycholate sodium (DOC), while in another embodiment the lytic agent is a non-animal derived lytic agent such as N-lauryl sarcosine sodium (NLS).
公开/授权文献
信息查询